Articles tagged with Chronic Obstructive Pulmonary Disease
Researchers at The University of Texas Medical Branch found that testosterone replacement therapy reduces respiratory hospitalizations in middle-aged and older men with chronic obstructive pulmonary disease (COPD). This suggests that testosterone replacement therapy may slow the progression of COPD in these individuals.
Researchers developed a three-factor model predicting burn patients at risk for acute respiratory distress syndrome (ARDS). The model includes inhalation injury extent, percentage of body burned, and von Willebrand factor levels. This prediction tool could guide clinical trials to prevent ARDS in high-risk patients.
Long-term exposure to secondhand smoke in childhood increases the risk of chronic obstructive pulmonary disease (COPD) death and other conditions in adulthood. Secondhand smoke exposure as an adult also raises mortality risks, particularly from COPD and ischemic heart disease.
Researchers found a specific single nucleotide polymorphism (SNP) associated with COPD and linked to the HLA-C gene, which presents proteins to immune cells. This discovery suggests a genetic link between autoimmune disease and COPD.
A small experimental study found that e-cigarette vapor disables key immune cells in the lung and boosts inflammation. The vapour impairs the activity of alveolar macrophages, which are crucial for removing dust particles, bacteria, and allergens from the air spaces.
A study found that nearly 40% of women with asthma may develop COPD, but certain factors such as smoking, obesity, and socioeconomic status may lower this risk. The researchers identified individual risk factors playing a more significant role in the development of COPD overlap syndrome than exposure to air pollution.
A randomized controlled trial found that inhaled vaporized cannabis did not improve or worsen exercise-related breathlessness in patients with advanced COPD. Despite some variability in response, the study's results suggest no clinically meaningful effect of cannabis on breathlessness during exercise.
A new study found that measuring blood telomeres can predict future risk of worsening COPD or death. Azithromycin treatment was shown to help patients with short telomeres stave off negative clinical outcomes, suggesting its potential as a biomarker for patient risk-stratification.
Researchers found that even mild COPD patients have lost over 40% of their small airways, suggesting early intervention is crucial. The study's findings could lead to the development of new drugs to treat patients with COPD at earlier stages.
A new study finds that antidepressant use in people with chronic obstructive pulmonary disease (COPD) is associated with a 20% increase in likelihood of death and a 15% increase in hospitalization due to respiratory-related symptoms. The study suggests strong association, but not cause and effect.
A new risk-score tool utilizing laboratory tests effectively identifies COPD patients at high risk of hospitalization due to a flare-up. The tool, known as the LIVE Score, allows for earlier interventions and improved patient care.
Research reveals that IL-26 is increased among chronic smokers with lung disease, mobilizing neutrophils and exacerbating bacterial infections. The study provides new insights into the pathogenic mechanisms behind COPD and chronic bronchitis, suggesting IL-26 as a promising molecular target for therapy.
Researchers developed a computational way of analyzing X-ray images of lungs to assess Chronic Obstructive Pulmonary Disease (COPD) and other lung diseases. The new method uses topology, combining CT scans, high-performance computing, and algorithms to identify lung function characteristics.
A large European study links biological dusts, gases, and fumes to a significantly increased risk of Chronic Obstructive Pulmonary Disease (COPD). The research found that exposure to certain occupational agents can increase the incidence of COPD by up to 120%.
Researchers at Helmholtz Zentrum München discovered a previously unknown pathogenic mechanism underlying COPD. By targeting the oxysterol pathway, they were able to prevent iBALT formation and immune cell migration, halting inflammation in an experimental model.
Researchers at Osaka University have found that the double deletion of tetraspanins CD9 and CD81 in mice causes progressive aging and shortened lifespan. The study reveals that CD9/CD81 DKO mice develop an accelerated aging syndrome, with symptoms including emphysema, osteoporosis, and skin and muscle atrophy.
A new study found that almost 100 million adults in China suffer from chronic obstructive pulmonary disease (COPD), with men having a higher prevalence than women. The study highlights the need for public health strategies to prevent COPD, including smoking cessation programs and stricter control of ambient air pollution.
Three-quarters of COPD cases have origins in poor lung function pathways beginning in childhood, amplified by adult factors. Childhood illnesses and exposures are key indicators of COPD risk.
A new study found that Tai Chi is equivalent to pulmonary rehabilitation in improving respiratory function and quality of life for patients with COPD. The slow, methodical exercise was shown to be effective in reducing symptoms and improving physical performance after 12 weeks of treatment.
Scientists have identified genetic patterns in Haemophilus influenzae that make certain strains more dangerous than others. This discovery may lead to the development of new treatments and vaccines for Chronic Obstructive Pulmonary Disease (COPD) patients.
Researchers studied 192 COPD patients over 15 years to understand how the nontypeable Haemophilus influenzae (NTHi) pathogen survives in human airways. The study reveals genetic changes that help the pathogen adapt and thrive, providing insights for developing a vaccine or treatment.
A genetic variant in the PDGFD gene has been identified as a key factor in adrenal suppression caused by corticosteroids. This discovery offers potential for personalized approaches to therapy, including screening patients at high risk of side effects or developing tailored monitoring plans.
A study published in European Respiratory Journal found that moderate and severe COPD exacerbations accelerate physical activity decline. Researchers recommend promoting interventions to increase physical activity after an exacerbation to improve outcomes.
Researchers at McGill University and Columbia University Irving Medical Center found that variations in large airway branches are associated with higher COPD prevalence. People with certain airway tree variations are more likely to have COPD, especially if they smoke, highlighting the importance of quitting smoking as the best antidote.
Researchers have identified new drug candidates that target multiple protein kinase families to reduce inflammation in COPD. The Narrow Spectrum Kinase Inhibitors (NSKIs) show promising anti-inflammatory effects and may constitute a breakthrough in treating advanced lung disease.
Researchers at Kumamoto University found that abnormalities in ion channels ENaC and CFTR reduce zinc delivery to lung epithelial cells, leading to excessive mucus production. This discovery sheds light on the role of zinc in pulmonary diseases and highlights the need for a therapeutic approach that considers transport mechanisms.
A study found that adults who ate more than two tomatoes or three portions of fresh fruit per day had slower lung function decline over a 10-year period. The researchers suggest that certain components in these foods might help restore lung damage caused by smoking.
Human emissions of vanadium have spiked since the start of the 21st century due to heavy oil use, surpassing natural sources combined. The health risks of airborne vanadium particles are not well documented but may impair respiratory functions and exacerbate conditions like asthma.
A new study published in The Lancet found that short-term exposure to air pollution on city streets can cancel out the beneficial health effects of exercise in adults over 60. Researchers recommend stricter air quality limits and better traffic-control measures, as well as increasing access to green spaces for people to exercise.
Research reveals that rheumatoid arthritis may increase the risk of developing chronic obstructive pulmonary disease (COPD). Individuals with chronic inflammatory conditions are at a higher risk, emphasizing the need for controlled inflammation and early symptom monitoring.
Between 1980 and 2014, US chronic respiratory disease deaths rose significantly, with a 29.7% increase overall. The majority of this growth occurred in specific regions, including central Appalachia for COPD, the Southwest for interstitial lung disease, and southern states for asthma.
A large study found that steroid inhalers used to treat asthma and COPD in people over 66 increase the risk of nontuberculous mycobacteria infections. The study suggests that these infections are chronic, difficult to treat, and associated with an increased risk of death.
A new antibody treatment has been shown to reduce the rate of exacerbations by nearly 20% in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD). The study found that patients with high eosinophil counts benefited more from the treatment, indicating a potential biomarker for the disease.
Nurses who regularly clean surfaces with disinfectants face a 22-32% increased risk of developing chronic obstructive pulmonary disease (COPD). Exposure to specific chemicals like glutaraldehyde, bleach, and quaternary ammonium compounds also increases COPD risk.
A new virtual model of mouse lung function has been developed to better understand the relative importance of different factors contributing to lung changes in chronic inflammation. The study found that changes in lung recruitment and elastic fiber density were mainly responsible for declining lung function.
A recent study found that current smoking in older people increases the risk of developing frailty. Frailty is a condition associated with decreased physiological reserve and increased vulnerability to adverse health outcomes.
The study found that COPD is largely caused by smoking and air pollution, while asthma's causes are less clear but include smoking and allergens. Interventions can prevent or treat both diseases, but many cases go undiagnosed or undertreated.
A study by Helmholtz Munich researchers found that certain subtypes of COPD are associated with changes in the lung microbiome, which may promote pathogenic bacteria. The findings suggest personalized medicine approaches should consider the microbiome when treating patients with specific COPD subtypes.
Researchers found that new opioid use among older adults with COPD is associated with a higher risk of coronary artery disease-related death. The study suggests that opioids may have negative effects on the heart, including lower blood oxygen levels and increased inflammatory factors.
Researchers found that faster administration of care was linked with lower mortality in patients with sepsis and septic shock. The study suggests that hospitals and health care systems should invest in infrastructure to get antibiotics to patients as soon as possible.
BU researcher Avrum Spira recognized for his work on early detection of lung cancer using Percepta RNA biomarker, as well as development of new drugs for chronic obstructive pulmonary disease (COPD). His research has made a direct impact on diagnosis and daily care of patients with lung cancer and COPD in the past 20 years.
In-hospital COPD mortality declined substantially between 2005 and 2014, with a 62% decrease in deaths among patients hospitalized for the condition. Women accounted for the majority of hospitalizations and in-hospital deaths, making up 57-58% and 51-55%, respectively.
A randomized controlled trial found that online pulmonary rehabilitation was non-inferior to in-person classes in improving exercise capacity and symptom control among patients with moderate COPD. The study used the MyPR application, which is free for UK patients with advanced COPD.
A new study found that smokers without chronic obstructive pulmonary disease (COPD) who experience vascular pruning, or the reduction of distal pulmonary blood vessels, are at a higher risk of death. Vascular pruning was not associated with an increased risk of death in smokers with COPD.
A new COPD National Action Plan was released by the NHLBI, outlining key goals to raise public awareness, advance research, improve patient care, and develop management strategies. The plan aims to empower people with COPD to recognize and reduce its burden, as well as promote education and training for healthcare professionals.
Acute COPD exacerbations significantly increase the risk of heart attack and stroke in people with cardiovascular disease or at high CVD risk. Researchers found that odds of these events were nearly four-fold higher within 30 days after an exacerbation.
UK researchers have made a breakthrough in treating severe lung disease by developing a home ventilation therapy that reduces hospital readmissions. The study, published in the Journal of the American Medical Association, found patients using this treatment were two-thirds less likely to be readmitted within 28 days.
A study published in JAMA found that adding home noninvasive ventilation to oxygen therapy for patients with persistent hypercapnia following a COPD flare-up significantly reduced time to hospital readmission or death. The 12-month risk of readmission or death was 63% vs 80% in the treatment and control groups, respectively.
Researchers found no evidence of increased risk of heart attack, depression, or self-harm in patients with COPD using varenicline. The medication is considered highly effective in helping smokers quit, addressing long-standing concerns among doctors.
A new study investigates the use of oxygen therapy via high-flow nasal tubes in patients with COPD experiencing exacerbations. The short-term trial found lower retained carbon dioxide levels compared to standard oxygen therapy, suggesting a potential benefit.
A new triple inhaler has shown a 20% reduction in chronic obstructive pulmonary disease (COPD) flare-ups in a year-long trial involving 2,691 patients. The study found that the inhaler improved lung function and reduced symptoms, with potential benefits for early diagnosis and targeted treatment.
A new study found that stem cell therapy reduces lung inflammation in a mouse model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The treatment also improves lung structure, suggesting it may repair damaged lungs.
A new study reveals a significant decrease in airway wall cells and certain inflammatory cells in smokers and mild to moderate COPD patients. The findings challenge the widely accepted description of airway inflammation in these individuals, suggesting a more complex underlying mechanism.
The new guidelines cover antibiotic and corticosteroid therapy for outpatients with mild and moderate exacerbations. The recommendations also include starting pulmonary rehabilitation 3 weeks after discharge from hospital following a severe exacerbation.
Researchers discovered that cigarette smoke silences the lung's natural self-healing process by blocking key receptors. Increasing these receptors can restore repair and lead to increased production of vital proteins, offering new hope for developing therapies for COPD patients.
A diet rich in fruit and vegetables is associated with a significantly lower risk of chronic lung disease (COPD) in former and current smokers. The study found that each additional daily serving was linked to a 4-8% lower risk, with the strongest influence coming from apples, green leafy vegetables, and peppers.
Current and former smokers with medical comorbidities are more likely to use e-cigarettes, which may be seen as a safer alternative to combustible cigarettes. The study found that e-cigarette use continues to rise, especially among present smokers with asthma or cardiovascular disease.
A study analyzing over 1.5 million Medicare records found that ICU care for COPD, heart failure, and heart attack patients may not be more beneficial than regular hospital care, with significant differences in cost of care.
A new treatment targeting COPD and other lung diseases has been identified in a study published in The FASEB Journal. FPS-ZM1, a RAGE antagonist compound, reverses the inflammatory response and has a protective role in COPD, according to researchers.
Researchers have identified 13 new genetic regions linked to chronic obstructive pulmonary disease (COPD), as well as overlap with asthma and pulmonary fibrosis. The study provides insight into the genetic basis of COPD and may lead to improved therapies for patients.